SLC7A11 and SATB2 associated disorder: In xCT+/+ as well as xCT−/− mice, the distance walked was unaffected by chronic SAS treatment in both the OF (Figures 5C,D; KW test, xCT+/+: p = 0.4502, xCT−/−: p = 0.9664) and EPM (Figures 5E,F; KW test, xCT+/+: p = 0.6306, xCT−/−: p = 0.9899).